Neutrophil serine proteinases activate human nonepithelial cells to produce inflammatory cytokines through protease-activated receptor 2

Journal of Immunology

Volumn 170, Issue 11, 2003, Pages 5690-5696

  Uehara, Akiko ^a   Muramoto, Koji ^a   Takada, Haruhiko ^a   Sugawara, Shunji ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CATHEPSIN G; CYTOKINE; GUANINE NUCLEOTIDE BINDING PROTEIN; INTERLEUKIN 8; LEUKOCYTE ELASTASE; LIGAND; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOBLASTIN; PEPTIDE; PHOSPHOLIPASE C; PROTEINASE ACTIVATED RECEPTOR 2; RECOMBINANT PROTEIN; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; SERINE PROTEINASE; TRYPSIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CELL ACTIVATION; CELL SURFACE; CHILD; CONTROLLED STUDY; EPITHELIUM CELL; FIBROBLAST; GINGIVA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREGULATION; INFLAMMATION; MOUTH MUCOSA; NEUTROPHIL; PERIODONTITIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION;

EID: 0037797300     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.11.5690     Document Type: Article

References (59)

1. Déry, O., C. U. Corvera. M. Steinhoff, and N. W. Bunnett. 1998. Proteinase activated receptors: novel mechanisms of signaling by serine proteases. Am. J. Physiol. 274:C1429.
2. Coughlin, S. R. 2000. Thrombin signalling and protease-activated receptors. Nature 407:258.
3. O'Brien, P. J., M. Molino, M. Kahn, and L. F. Brass. 2001. Protease activated receptors: theme and variations. Oncogene 20:1570.
4. Vergnolle, N., J. L. Wallace, N. W. Bunnett, and M. D. Hollenberg. 2001. Protease-activated receptors in inflammation, neuronal signaling and pain. Trends Pharmacol. Sci. 22:146.
5. Rao, N. V., N. G. Wehner, B. C. Marshall. W. R. Gray, B. H. Gray, and J. R. Hoidal. 1991. Characterization of proteinase-3 (PR-3), a neutrophil serine proteinase: structural and functional properties. J. Biol. Chem. 266:9540.
6. Bories, D., M.-C. Raynal, D. H. Solomon. Z. Darzynkiewicz, and Y. E. Cayre. 1989. Down-regulation of a serine protease, myeloblastin, causes growth arrest and differentiation of promyelocytic leukemia cells. Cell 59:959.
7. Owen, C. A., and E. J. Campbell. 1999. The cell biology of leukocyte-mediated proteolysis. J. Leukocyte Biol. 65:137.
8. Uehara. A., S. Sugawara, K. Muramoto, and H. Takada. 2002. Activation of human oral epithelial cells by neutrophil proteinase 3 through protease-activated receptor-2. J. Immunol. 169:4594.
9. Thompson, R. C., and K. Ohlsson. 1986. Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor a potent inhibitor of leukocyte elastase. Proc. Natl. Acad. Sci. USA 83:6692.
10. Abe, T., N. Kobayashi, K. Yoshimura, B. C. Trapnell, H. Kim, R. C. Hubbard, M. T. Brewer, R. C. Thompson, and R. G. Crystal. 1991. Expression of the secretory leukoprotease inhibitor gene in epithelial cells. J. Clin. Invest. 87:2207
11. Sumi, Y., H. Muramatsu. K. Hata, M. Ueda, and T. Muramatsu. 2000. Secretory leukocyte protease inhibitor is a novel inhibitor of fibroblast-mediated collagen gel contraction. Exp. Cell Res. 256:203.
12. Böhm. B., T. Aigner, R. Kinne, and H. Burkhardt. 1992. The serine-protease inhibitor of cartilage matrix is not a chondrocytic gene product. Eur. J. Biochem. 207:773.
13. Jin, F., C. Nathan, D. Radzioch, and A. Ding. 1997. Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide. Cell 88:417.
14. Sallenove, J.-M., M. Si-Ta har, G. Cox, M. Chignard, and J. Gauldie. 1997. Secretory leukocyte proteinase inhibitor is a major leukocyte elastase inhibitor in human neutrophils. J. Leukocyte Biol. 61:695.
15. Suzumori, N., M. Sato, T. Yoneda, Y. Ozaki, H. Takagi, and K. Suzumori. 1999. Expression of secretory leukocyte protease inhibitor in women with endometriosis. Fertil. Steril. 72:857.
16. Mihara. A., and G. M. Tremblay. 2001. Human alveolar macrophages express elafin and secretory leukocyte protease inhibitor. Z. Naturforsch., C 56:291.
17. Takada, H., J. Mihara, I. Morisaki, and S. Hamada. 1991. Production of cytokines by human gingival fibroblasts, In Periodontal Disease: Pathogens and Host Immune Responses. S. Hamada, S. C. Holt, and J. R. McGhee, eds. Quintessence Publishing, Tokyo, Japan, p. 265.
18. Sugawara, S., A. Sugiyama, E. Nemoto, H. Rikiishi, and H. Takada. 1998. Heterogeneous expression and release of CD14 by human gingival fibroblasts: characterization and CD14-mediated interleukin-8 secretion in response to lipopolysaccharide. Infect. Immun. 66:3043.
19. Nemoto, E., S. Sugawara. H. Tada, H. Takada, H. Shimauchi, and H. Horiuchi. 2000. Cleavage of CD14 on human gingival fibroblasts cocultured with activated neutrophils is mediated by human leukocyte elastase resulting in down-regulation of lipopolysaccharide-induced IL-8 production. J. Immunol. 165:5807.
20. Momose, F., T. Araida, A. Negishi, H. Ichijo, S. Shioda, and S. Sasaki. 1989. Variant sublines with different metastatic potentials selected in nude mice from human oral squamous cell carcinomas. J. Oral Pathol. Med. 18:391.
21. Miyauchi, S., T. Moroyama, T. Sakamoto, T. Okamoto, and K. Takada. 1985. Establishment of human tumor cell line (Ueda-1) derived from squamous cell carcinoma of the floor of the mouth. Jpn. J. Oral Maxillofac. Surg. 31:1347.
22. Eagle, H. 1955. Propagation in a fluid medium of a human epidermoid carcinoma, strain KB. Proc. Soc. Exp. Biol. Med. 89:362.
23. Sugawara, S., A. Uehara, T. Nochi, T. Yamaguchi, H. Ueda, A. Sugiyama, K. Hanzawa, K. Kumagai, H. Okamura, and H. Takada. 2001. Neutrophil proteinase 3-mediated induction of bioactive IL-18 secretion by human oral epithelial cells. J. Immunol. 167:6568.
24. Saitoh, H., T. Masuda, S. Shimura, T. Fushimi, and K. Shirato. 2001. Secretion and gene expression of secretory leukocyte protease inhibitor by human airway submucosal glands. Am. J. Physiol. 280:L79.
25. Vu, T. K., D. T. Hung, V. I. Wheaton, and S. R. Coughlin. 1991. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64:1057.
26. Storck, J., B. Küsters, M. Vahland, C. Morys-Wortmann, and E. R. Zimmermann. 1996. Trypsin induced von Willebrand factor release from human endothelial cells is mediated by PAR-2 activation. Thromb. Res. 84:463.
27. Schmidt, V. A., W. C. Nierman. D. R. Maglott, L. D. Cupit, K. A. Moskowitz, J. A. Wainer, and W. F. Bahou. 1998. The human proteinase-activated receptor-3 (PAR-3) gene: identification within a PAR gene cluster and characterization in vascular endothelial cells and platelets. J. Biol. Chem. 273:15061.
28. Xu, W.-F., H. Andersen, T. E. Whitmore, S. R. Presnell, D. P. Yee, A. Ching, T. Gilbert, E. W. Davie, and D. C. Foster. 1998. Cloning and characterization of human protease-activated receptor 4. Proc. Natl. Acad. Sci. USA 95:6642.
29. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680.
30. Molino, M., E. S. Bamathan, R. Numerof, J. Clark, M. Dreyer, A. Cumashi, J. A. Hoxie, N. Schechter, M. Woolkalis, and L. F. Brass. 1997. Interactions of mast cell tryptase with thrombin receptors and PAR-2. J. Biol. Chem. 272:4043.
31. Tateno, H., A. Saneyoshi, T. Ogawa, K. Muramoto, H. Kamiya, and M. Saneyoshi. 1998. Isolation and characterization of rhamnose-binding lectins from eggs of steelhead trout (Oncorhynchus mykiss) homologous to low density lipoprotein receptor superfamily. J. Biol. Chem. 273:19190.
32. Campbell, E. J., M. A. Campbell, and C. A. Owen. 2000. Bioactive proteinase 3 on the cell surface of human neutrophils: quantification, catalytic activity, and susceptibility to inhibition. J. Immunol. 165:3366.
33. Schalkwijk, J., A. Chang, P. Janssen, G. J. de Jongh, and P. D Mier. 1990. Skin-derived antileukoproteinase (SKALP): characterization of two new elastase inhibitors from psoriatic epidermis. Br. J. Dermatol. 122:641.
34. Wiedow, O., J. Schröder, H. Gregory, J. A. Young, and E. Christopher. 1990. Elafin: an elastase-specific inhibitor of human skin. Purification, characterization, and complete amino acid sequence. J. Biol. Chem. 265:14791.
35. Wiedow, O., J. Luademann, and B. Utecht. 1991. Elafin is a potent inhibitor of proteinase 3. Biochem. Biophys. Res. Commun. 174:6.
36. Pfundt, R., F. van Ruissen, I. M. J. J. van Vlijmen-Willems, H. A. C. Alkemade, P. L. J. M. Zeeuwen, P. H. Jap, H. Dijkman, J. Fransen, H. Croes, P. E. J. van Erp, and J. Schalkwijk. 1996. Constitutive and inducible expression of SKALP/elafin provides anti-elastase defense in human epithelia. J. Clin. Invest. 98:1389.
37. Robinson, P. A., J. J. Marley, A. S. High, and W. J. Humw. 1994. Differential expression of protease inhibitor and small proline-rich protein genes between normal human oral tissue and odontogenic keratinocytes. Arch. Oral Biol. 39:251.
38. Bieth, J. G. 1999. Leukocyte elastase. In Handbook of Proteolytic Enzymes. A. J. Barrett, N. D. Rawlings, and J. F. Woessner, eds. Academic Press, San Diego, CA, p. 54.
39. Salvesen, G. S. 1999. Cathepsin G. In Handbook of Proteolytic Enzymes. A. J. Barrett, N. D. Rawlings, and J. F. Woessner, eds. Academic Press, San Diego, CA, p. 60.
40. Hoidal, J. R. 1999. Myeloblastin. In Handbook of Proteolytic Enzymes. A. J. Barrett, N. D. Rawlings, and J. F. Woessner, eds. Academic Press, San Diego, CA, p. 62.
41. Renesto, P., M. Si-Tahar, M. Moniatte, V. Balloy, A. Van Dorsselaer, D. Pidard, and M. Chignard. 1997. Specific inhibition of thrombin-induced cell activation by the neutrophil proteinases elastase, cathepsin G, and proteinase 3: evidence for distinct cleavage sites within the aminoterminal domain of the thrombin receptor. Blood 89:1944.
42. Cumashi, A., H. Ansuini, N. Celli, A. De Blasi, P. J. O'Brien, L. F. Brass, and M. Molino. 2001. Neutrophil proteases can inactivate human PAR3 and abolish the co-receptor function of PAR3 on murine platelets. Thromb. Haemostasis 85:533.
43. Loew, D., C. Perrault, M. Morales, S. Moog, C. Ravanat, S. Schuhler, R. Arcone, C. Pietropaolo, J.-P. Cazenave, A. van Dorsselaer, and F. Lanza. 2000. Proteolysis of the exodomain of recombinant protease-activated receptors: prediction of receptor activation or inactivation by MALDI mass spectrometry. Biochemistry 39:10812
44. Suchett-Kaye, G., J. J. Morrier, and O. Barsotti. 1998. Interactions between nonimmune host cells and the immune system during periodontal disease: role of the gingival keratinocyte. Crit. Rev. Oral Biol. Med. 9:292.
45. Kunimatsu, K., Y. Ozaki, Y. Hara, Y. Aoki, K. Yamamoto, and I. Kato. 1997, Immunohistochemical study of cathepsin G and medullasin in inflamed gingival tissues from periodontal patients. J. Periodont. Res. 32:264.
46. Tervahartiala, T., Y. T. Konttinen, T. Ingman, R. Häyrinen-Immonen, Y. Ding and T. Sorsa. 1996. Cathepsin G in gingival tissue and crevicular fluid in adult periodontitis. J. Clin. Periodontol. 23:68.
47. Wolff, L. F., N. J. Koller, Q. T. Smith, A. Mathur, and D. Aeppli. 1997. Subgingival temperature: relation to gingival crevicular fluid enzymes, cytokines, and subgingival plaque micro-organisms. J. Clin. Periodontol. 24:900.
48. Liou, T. G., and E. J. Campbell. 1995. Nonisotropic enzyme-inhibitor interactions: a novel nonoxidative mechanism for quantum proteolysis by human neutrophils. Biochemistry 34:16171.
49. Owen, C. A., M. A. Campbell. P. L. Sannes, S. S. Boukedes, and E. J. Campbell. 1995. Cell surface-bound elastase and cathepsin G on human neutrophils: a novel, non-oxidative mechanism by which neutrophils focus and preserve catalytic activity of serine proteinases. J. Cell Biol. 131:775.
50. Owen, C. A., M. A. Campbell, S. S. Boukedes, and E. J. Campbell. 1997. Cytokines regulate membrane-bound leukocyte elastase on neutrophils: a novel mechanism for effector activity. Am. J. Physiol. 272:L385.
51. Baggiolini, M., B. Dewald, and B. Moser. 1994. Interleukin-8 and related chemotactic cytokines; CXC and CC chemokines. Adv. Immunol. 55:97.
52. Gu, L., S. Tseng, R. M. Homer, C. Tam, M. Loda, and B. J. Rollins. 2000. Control of TH2 polarization by the chemokine monocyte chemoattractant proein-1. Nature 404:407.
53. Huang, D., J. Wang, P. Kivisakk, B. J. Rollins, and R. M. Ransohoff. 2001. Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis. J. Exp. Med. 193:713.
54. D'Andrea, M. R., C. K. Derian, D. Leturcq, S. M. Baker, A. Brunmark, P. Ling, A. L. Darrow, R. J. Santulli, L. F. Brass, and P. Andrade-Gordon. 1998. Characterization of protease-activated receptor-2 immunoreactivity in normal human tissues. J. Histochem. Cytochem. 46:157.
55. Nystedt, S., V. Ramakrishnan, and J. Sundelin. 1996. The proteinase-activated receptor 2 is induced by inflammatory mediators in human endothelial cells: comparison with thrombin receptor. J. Biol. Chem. 271:14910.
56. Knight, D. A., S. Lim, A. K. Scaffidi, N. Roche, K. F. Chung, G. A. Stewart, and P. J. Thompson. 2001. Protease-activated receptors in human airways: upregulation of PAR-2 in respiratory epithelium from patients with asthma. J. Allergy Clin. Immunol. 108:797.
57. Lindner, J. R., M. L. Kahn, S. R. Coughlin, G. R. Sambrano, E. Schauble, D. Bernstein, D. Foy, A. Hafezi-Moghadam, and K. Ley. 2000. Delayed onset of inflammation in protease-activated receptor-2-deficient mice. J. Immunol. 165:6504.
58. Kawagoe, J., T. Takizawa, J. Matsumoto, M. Tamiya, S. E. Meek, A. J. H. Smith, G. D. Hunter, R. Plevin, N. Saito, T. Kanke, et al. 2002. Effect of proteaseactivated receptor-2 deficiency on allergic dermatitis in the mouse ear. Jpn. J. Pharmacol. 88:77.
59. Schmidlin, F., S. Amadesi, K. Dabbagh, D. E. Lewis, P. Knott, N. W. Bunnett, P. R. Gater, P. Geppetti, C. Bertrand, and M. E. Stevens., 2002. Protease-activated receptor 2 mediates eosinophil infiltration and hyperreactivity in allergic inflammation of the airway. J. Immunol. 169:5315.